Lorenzo Galluzzi, PhD
Scientific Advisory Board
Dr. Galluzzi is and Italian and French cell biologist who is known for his experimental contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He is one of the most cited young researchers in the world, and one of the most cited doctors in Italy.
Dr. Galluzzi is Assistant Professor of Cell Biology at the Department of Radiation Oncology at Weill Cornell Medical College, New York and Assistant Professor and Adjunct the Department of Dermatology at Yale School of Medicine, New Haven. He is Associate Director of the European Academy for Tumor Immunology (EATI) and a Founding Member of the European Research Institute for Integrated Cellular Pathology (ERI-ICP).
Dr. Galluzzi has provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. He has published more than 400 scientific articles in more than 100 different international peer-reviewed journals, collaborating with more than 3,000 co-authors. According to Google Scholar, Galluzzi has a h-index of 109, placing him amongst the top-50 Italian scientists working in biomedical sciences.
In addition to his research and dissemination activity, Galluzzi currently operates as Editor-in-Chief of three journals: OncoImmunology (which he co-founded with Dr. Guido Kroemer and Dr. Laurence Zitvogel in 2011), International Review of Cell and Molecular Biology, and Molecular and Cellular Oncology (which he co-founded with Dr. Guido Kroemer in 2013). Galluzzi also serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease and Aging.